DTL
NBIX icon

Dynamic Technology Lab’s Neurocrine Biosciences NBIX Stock Holding History

Dynamic Technology Lab’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,370
Closed -$267K – 1282
2023
Q3 		$267K Buy
+2,370
New +$250K 0.03% 704
2023
Q2 		– Sell
-6,500
Closed -$658K – 1282
2023
Q1 		$658K Buy
+6,500
New +$676K 0.06% 529
2022
Q1 		– Sell
-3,434
Closed -$292K – 1365
2021
Q4 		$292K Buy
+3,434
New +$316K 0.03% 806
2020
Q4 		– Sell
-6,145
Closed -$591K – 1222
2020
Q3 		$591K Buy
+6,145
New +$711K 0.1% 372
2019
Q4 		– Sell
-10,188
Closed -$918K – 1192
2019
Q3 		$918K Buy
+10,188
New +$952K 0.16% 172
2019
Q1 		– Sell
-4,814
Closed -$343K – 1216
2018
Q4 		$343K Sell
4,814
-5,179
-52% -$496K 0.06% 575
2018
Q3 		$1.23M Buy
+9,993
New +$1.13M 0.17% 160
2018
Q2 		– Sell
-5,461
Closed -$453K – 1208
2018
Q1 		$453K Buy
+5,461
New +$461K 0.07% 526
2017
Q1 		– Sell
-11,601
Closed -$449K – 1159
2016
Q4 		$449K Buy
11,601
+2,991
+35% +$135K 0.12% 311
2016
Q3 		$437K Buy
+8,610
New +$429K 0.12% 303
2015
Q4 		– Sell
-6,000
Closed -$239K – 1028
2015
Q3 		$239K Buy
+6,000
New +$290K 0.08% 553
2014
Q1 		– Sell
-31,519
Closed -$294K – 694
2013
Q4 		$294K Buy
+31,519
New +$308K 0.2% 201

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dynamic Technology Lab's NBIX Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Neurocrine Biosciences (NBIX) in Q4 2023, closing a stake of 2,370 shares — an estimated $267K sold.

Dynamic Technology Lab first reported a position in NBIX in Q4 2013 and held it in 12 quarters. The position peaked at $1.23M in Q3 2018. 554 funds tracked by Wall St. Rank hold NBIX as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Neurocrine Biosciences position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 2,370 Neurocrine Biosciences shares in Q4 2023, an estimated $267K.
  • Dynamic Technology Lab first reported a position in Neurocrine Biosciences in Q4 2013 and held it in 12 quarters.
  • Dynamic Technology Lab's Neurocrine Biosciences position peaked at $1.23M in Q3 2018.
  • 554 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.